1
Roll Calls
Advancing Education on Biosimilars Act of 2021
Policy Area: Health
Sponsor: Sen. Hassan, Margaret Wood [D-NH] (D-NH)
Latest Action (2021-04-23): Became Public Law No: 117-8.
Advancing Education on Biosimilars Act of 2021 This bill requires the Food and Drug Administration (FDA) to advance education and awareness among health care providers about biological products as appropriate, including by developing or improving continuing education programs that address the prescribing of biological products and biosimilars. (A biosimilar is a biological product that is highly similar to an FDA-approved reference biological product and has no clinically meaningful differences from that reference product.) The FDA may also maintain and operate a website to provide educational materials about biological products.
Subjects: Drug safety, medical device, and laboratory regulation, Government information and archives, Health personnel, Licensing and registrations, Medical education, Prescription drugs
Filter by Yea, Nay, or Absent
How members voted on S164. 289 total positions across all roll calls for this bill.
| Member | Date | Question | Vote | Result |
|---|---|---|---|---|
| Robert B. Aderholt (R-Alabama) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Jake Auchincloss (D-Massachusetts) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Mark E. Amodei (R-Nevada) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Alma S. Adams (D-North Carolina) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Pete Aguilar (D-California) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Rick W. Allen (R-Georgia) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Jodey C. Arrington (R-Texas) | 2021-04-14 | 2/3 Yea-And-Nay | Not Voting | Passed |
| Sanford D. Bishop (D-Georgia) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Cliff Bentz (R-Oregon) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Stephanie I. Bice (R-Oklahoma) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Lauren Boebert (R-Colorado) | 2021-04-14 | 2/3 Yea-And-Nay | Not Voting | Passed |
| Gus M. Bilirakis (R-Florida) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Vern Buchanan (R-Florida) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Suzanne Bonamici (D-Oregon) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Joyce Beatty (D-Ohio) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Andy Barr (R-Kentucky) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Julia Brownley (D-California) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Ami Bera (D-California) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Brian Babin (R-Texas) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Donald S. Beyer (D-Virginia) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Mike Bost (R-Illinois) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Brendan F. Boyle (D-Pennsylvania) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Don Bacon (R-Nebraska) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Jim Banks (R-Indiana) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Nanette Diaz Barragán (D-California) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Jack Bergman (R-Michigan) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Andy Biggs (R-Arizona) | 2021-04-14 | 2/3 Yea-And-Nay | Nay | Passed |
| Lisa Blunt Rochester (D-Delaware) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Ted Budd (R-North Carolina) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Troy Balderson (R-Ohio) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| James R. Baird (R-Indiana) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Tim Burchett (R-Tennessee) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Ken Calvert (R-California) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| James E. Clyburn (D-South Carolina) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Kat Cammack (R-Florida) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| John R. Carter (R-Texas) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Tom Cole (R-Oklahoma) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Ed Case (D-Hawaii) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Jim Costa (D-California) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Emanuel Cleaver (D-Missouri) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Henry Cuellar (D-Texas) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Kathy Castor (D-Florida) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Yvette D. Clarke (D-New York) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Steve Cohen (D-Tennessee) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Joe Courtney (D-Connecticut) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| André Carson (D-Indiana) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Judy Chu (D-California) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Eric A. "Rick" Crawford (R-Arkansas) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Joaquin Castro (D-Texas) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
| Katherine M. Clark (D-Massachusetts) | 2021-04-14 | 2/3 Yea-And-Nay | Yea | Passed |
Showing 50 of 289 positions. JavaScript-enabled view supports filter by Yea/Nay/Absent and pagination.
Interactive features require JavaScript. Static data shown above.
S164 is the Advancing Education on Biosimilars Act of 2021, introduced in the Senate of the 119th U.S. Congress by Sen. Hassan, Margaret Wood [D-NH] (D-NH). Advancing Education on Biosimilars Act of 2021 This bill requires the Food and Drug Administration (FDA) to advance education and awareness among health care providers about biological products as appropriate, including by developing or improving continuing education programs that address the prescribing of biological products and biosimilars. (A biosimilar is a biological product that is highly similar to an FDA-approved reference biological product and has no clinically meaningful differences from that reference product.) The FDA may also maintain and operate a website to provide educational materials about biological products.
S164 was sponsored by Sen. Hassan, Margaret Wood [D-NH] (D-NH). Cosponsors and roll-call positions are listed on this page.
As of 2021-04-23, S164 Became Public Law No: 117-8..
S164 has had 1 roll-call vote on record. The most recent: 2021-04-14 — 2/3 Yea-And-Nay (Passed).
S164 is categorized under "Health." Browse other bills in this area at /topic-health/.
Each member’s vote is shown on this page, with party affiliation, state, and the official vote question. Click any member to see their full voting record.